Capula Management LTD Vericel Corp Transaction History
Capula Management LTD
- $9.84 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
295Shares Held
54.3MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$254 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$112 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$88.6 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$77.7 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$76.8 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.49B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...